| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Beam Therapeutics Inc. | CEO, Director | Common Stock | 987K | $24.3M | $24.63 | 02 Oct 2025 | Direct |
| Beam Therapeutics Inc. | CEO, Director | Stock Option (Right to Buy) | 19.3K | $3.78M | $24.40 | 02 Oct 2025 | Direct |
| Beam Therapeutics Inc. | CEO, Director | Common Stock | 103K | $2.22M | $21.55 | 01 Oct 2025 | By John M. Evans, III 2018 Irrevocable Trust |
| Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 15.5K | 09 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | 01 Oct 2025 | 6 | -$1.19M | 4 | CEO, Director | 03 Oct 2025, 16:05 |
| BEAM | Beam Therapeutics Inc. | 01 Apr 2025 | 1 | -$563K | 4 | CEO, Director | 03 Apr 2025, 21:52 |
| BEAM | Beam Therapeutics Inc. | 31 Mar 2025 | 1 | $0 | 4 | CEO, Director | 02 Apr 2025, 19:10 |
| BEAM | Beam Therapeutics Inc. | 30 Jan 2025 | 2 | $20.1K | 4/A | CEO, Director | 02 Apr 2025, 16:05 |
| BEAM | Beam Therapeutics Inc. | 30 Sep 2024 | 1 | -$1.48M | 4 | CEO, Director | 02 Oct 2024, 17:49 |
| BEAM | Beam Therapeutics Inc. | 27 Jun 2024 | 1 | -$1.47M | 4 | CEO, Director | 28 Jun 2024, 16:15 |
| BEAM | Beam Therapeutics Inc. | 01 Apr 2024 | 3 | -$582K | 4 | CEO, Director | 03 Apr 2024, 19:36 |
| BEAM | Beam Therapeutics Inc. | 28 Mar 2024 | 2 | -$2.03M | 4 | CEO, Director | 01 Apr 2024, 16:10 |
| BEAM | Beam Therapeutics Inc. | 31 Jan 2024 | 2 | $2.26M | 4 | CEO, Director | 02 Feb 2024, 16:05 |
| BEAM | Beam Therapeutics Inc. | 03 Apr 2023 | 2 | -$345K | 4 | CEO, Director | 05 Apr 2023, 20:30 |
| BEAM | Beam Therapeutics Inc. | 31 Jan 2023 | 5 | $100K | 4 | CEO, Director | 31 Mar 2023, 19:48 |
| BEAM | Beam Therapeutics Inc. | 31 Oct 2022 | 8 | -$2.32M | 4 | CEO, Director | 02 Nov 2022, 16:30 |
| BEAM | Beam Therapeutics Inc. | 28 Jul 2022 | 9 | -$3.29M | 4 | CEO, Director | 29 Jul 2022, 16:06 |
| VERV | Verve Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 17:00 |
| BEAM | Beam Therapeutics Inc. | 28 Apr 2022 | 14 | -$1.76M | 4 | CEO, Director | 02 May 2022, 18:51 |
| BEAM | Beam Therapeutics Inc. | 31 Mar 2022 | 2 | -$370K | 4 | CEO, Director | 04 Apr 2022, 20:27 |
| BEAM | Beam Therapeutics Inc. | 31 Jan 2022 | 16 | -$3.24M | 4/A | CEO, Director | 02 Feb 2022, 17:00 |
| BEAM | Beam Therapeutics Inc. | 06 Oct 2021 | 10 | -$3.97M | 4 | CEO, Director | 08 Oct 2021, 16:21 |
| BEAM | Beam Therapeutics Inc. | 19 Aug 2021 | 8 | -$1.98M | 4 | CEO, Director | 20 Aug 2021, 18:05 |
| BEAM | Beam Therapeutics Inc. | 07 Jul 2021 | 15 | -$2.67M | 4 | CEO, Director | 08 Jul 2021, 18:00 |
| BEAM | Beam Therapeutics Inc. | 25 Jun 2021 | 3 | $0 | 4 | Chief Executive Officer, Director | 30 Jun 2021, 18:00 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | Director | 16 Jun 2021, 19:37 |
| BEAM | Beam Therapeutics Inc. | 05 Feb 2020 | 2 | $0 | 4/A | CEO, Director | 21 Sep 2021, 18:00 |